Close Menu

NEW YORK – NeoGenomics said late on Wednesday that it has priced a public offering of its common stock and convertible senior notes for a total of $500 million in gross proceeds.

The Fort Myers, Florida-based firm is offering 4,081,632 shares of its common stock at $49.00 per share. It also is offering $300 million aggregate principal amount of its .25 percent convertible senior notes due January 2028 for gross proceeds of $300 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Financial Times reports the US bolstering its ability to track SARS-CoV-2 alterations.

The New York Times reports that Cedars-Sinai researchers have uncovered a new strain of SARS-CoV-2 in Southern California.

In Nucleic Acids Research this week: pan-cancer atlas focus on miRNA biogenesis mutations, methylation analysis of pig skeletal muscles, and more.

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.